# Cosmetique Active International clinical trials: 55 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 55 trials with Cosmetique Active International as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Cosmetique Active International: 55 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/cosmetique-active-international

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 55
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 55, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 17, 2026 | NCT07537595 | Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) \[400-450nm\] | Cosmetique Active International | Observational | Completed | Skin Pigmentation, Healthy Volunteers, Hyperpigmentation | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537595) |
| February 24, 2026 | NCT07429786 | Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling... | Cosmetique Active International | Not applicable | Not yet recruiting | Hyperpigmentation, Melasma, Solar Lentigo, Peeling | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07429786) |
| January 12, 2026 | NCT07335003 | Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic... | Cosmetique Active International | Not applicable | Recruiting | Actinic Keratosis (AK) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335003) |
| November 20, 2025 | NCT07239726 | CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON... | Cosmetique Active International | Not applicable | Not yet recruiting | Solar Lentigo | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07239726) |
| August 6, 2025 | NCT07107854 | EVALUATION OF THE EFFICACY OF COSMETIC PRODUCT IN ADULTS SUBJECTS WITH MILD TO MODERATE ACNE | Cosmetique Active International | Observational | Completed | Acne | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07107854) |
| February 14, 2025 | NCT06827392 | Photoprotection Efficiency with Sunscreen Formulas Under Visible Light Exposure. | Cosmetique Active International | Observational | Completed | Efficiency of Agents, Against Pigmentation Induced by Visible Light Exposures | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06827392) |
| February 12, 2025 | NCT06822335 | Clinical Efficacy of the Product in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) Subjects | Cosmetique Active International | Observational | Completed | Acne, Post-inflammatory Hyperpigmentation | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06822335) |
| January 31, 2025 | NCT06803901 | Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure | Cosmetique Active International | Observational | Completed | Efficacy of Sunscreen Products, Healthy Back Skin, Pigmentation Induced by Visible Light Exposure | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06803901) |
| January 28, 2025 | NCT06796205 | Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure. | Cosmetique Active International | Observational | Completed | Visible Light Exposure on Healthy Back Skin | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796205) |
| January 28, 2025 | NCT06796192 | Evaluate the Photoprotection Efficacy of Sunscreen Formulas Under Visible Light Exposure | Cosmetique Active International | Observational | Completed | Study the Protection Potency of Sunscreen Products Against Pigmentation Induced by Visible Light Exposure on Healthy... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796192) |
| January 28, 2025 | NCT06796179 | Determine the Photoprotection Efficacy of Seven Sunscreen Products Under Visible Light Exposure. | Cosmetique Active International | Observational | Completed | Visible Light Exposure on Healthy Back Skin | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796179) |
| January 28, 2025 | NCT06796153 | Photoprotection Efficacy of Different Topical Agents Under Visible Light Exposure | Cosmetique Active International | Observational | Completed | Visible Light Exposure on Healthy Back Skin | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796153) |
| January 28, 2025 | NCT06796140 | Photoprotection Efficacy of a Sunscreen Under Visible Light Exposure by Using Two Different Simulators | Cosmetique Active International | Observational | Completed | Visible Light Exposures on Healthy Back Skin | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796140) |
| January 28, 2025 | NCT06796088 | Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure | Cosmetique Active International | Observational | Completed | Study the Potency of Sunscreen to Protect Against the Pigmentation Induced by Visible Light Exposure on Healthy Back... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796088) |
| January 28, 2025 | NCT06796010 | Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure | Cosmetique Active International | Observational | Completed | Visible Light Exposure, Healthy Back Skin | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796010) |
| January 22, 2025 | NCT06787846 | EFFICACY and TOLERABILITY of TESTED FORMULA VS. HYDROQUINONE 4% in the TREATMENT of FACIAL MELASMA | Cosmetique Active International | Not applicable | Completed | Melasma | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06787846) |
| January 22, 2025 | NCT06786442 | Clinical Efficacy Evaluation of a Skincare Product for Acne Face, Upper Chest and Back Used by Multiphototype Population Under... | Cosmetique Active International | Not applicable | Completed | Acne | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06786442) |
| January 13, 2025 | NCT06770127 | Efficacy of La Roche Posay Routine in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) | Cosmetique Active International | Observational | Completed | Acne, Postinflammatory Hyperpigmentation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06770127) |
| November 20, 2024 | NCT06697288 | Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging | Cosmetique Active International | Not applicable | Recruiting | Aging | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06697288) |
| September 19, 2024 | NCT06590779 | Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss | Cosmetique Active International | Not applicable | Unknown | Androgenetic Alopecia | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06590779) |
| July 23, 2024 | NCT06516224 | Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma | Cosmetique Active International | Not applicable | Unknown | Melasma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06516224) |
| June 20, 2024 | NCT06467032 | Effectiveness and Tolerance of Cicaplast Baume B5 After Superficial CO2 Laser Resurfacing | Cosmetique Active International | Not applicable | Completed | Wound Heal | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06467032) |
| June 18, 2024 | NCT06463925 | Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk | Cosmetique Active International | Not applicable | Unknown | Acne | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06463925) |
| March 20, 2024 | NCT06320314 | Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins | Cosmetique Active International | Not applicable | Unknown | Hyperpigmentation | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06320314) |
| February 26, 2024 | NCT06278948 | Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma | Cosmetique Active International | Not applicable | Unknown | Melasma | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06278948) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 24 |
| Observational | 31 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 40 |
| Unknown | 9 |
| Terminated | 2 |
| Not yet recruiting | 2 |
| Recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Acne Vulgaris | 13 |
| Hyperpigmentation | 11 |
| Melanosis | 9 |
| Dermatitis, Atopic | 6 |
| Skin Diseases | 3 |
| Keratosis, Actinic | 2 |
| Eczema | 2 |
| Alopecia | 2 |
| Hypersensitivity | 1 |
| Acne, Adult | 1 |
| Facies | 1 |
| Hand Dermatoses | 1 |
| Rosacea | 1 |
| Asthma | 1 |
| Food Hypersensitivity | 1 |
| Rhinitis, Allergic | 1 |
| Dermatitis | 1 |
| Dandruff | 1 |
| Pigmentation Disorders | 1 |
| Disease | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Charter schools in the United States](https://specstream.ai/data/businesses/charter-schools/united-states)
- [Hospices in the United States](https://specstream.ai/data/businesses/hospices/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [Agricultural services in the United States](https://specstream.ai/data/businesses/agricultural-services/united-states)
- [Doctors' offices in the United States](https://specstream.ai/data/businesses/doctors-offices/united-states)
- [Life insurance agencies in the United States](https://specstream.ai/data/businesses/life-insurance-agencies/united-states)
